URSA-PHARM-R08: Patients with Active PDC Medication
  • 27 Apr 2023
  • 1 Minute to read
  • Dark
    Light

URSA-PHARM-R08: Patients with Active PDC Medication

  • Dark
    Light

Article summary

Measure Description

Includes patient periods of active plan membership during which the patient has one or more active medication therapy episode for any of the three medication classes included in the PDC measures; (1) Oral Antidiabetics, (2) Oral ACEI/ARBs, or (3) Statins

Metadata

  • Measure Type: Registry
  • Temporal Structure: Entity
  • Component Class: Normal-Form
  • Denominator Case Field: Patient ID
  • Target Direction: None

None.

FAQs

None.


Was this article helpful?